Hakkında
Professor Ros Eeles is Professor of Oncogenetics at The Institute of Cancer Research, University of London UK. She trained at The University of Cambridge, UK and St Thomas' Hospital, London. She is a Fellow of the Royal College of Physicians and Royal College of Radiologists (Clinical Oncology Faculty), London UK. She is accredited in Clinical Oncology and has extensive sub-specialist experience in Cancer Genetics.
Professor Eeles' oncological practice is in radiotherapy and chemotherapy for Uro-Oncology. Her cancer genetics practice involves cancer risk assessment, screening advice and management of increased cancer risk in adults for any cancer site. She is also an expert in how the new cancer genetics impacts on treatment decisions. She has edited a specialist textbook on Cancer Prevention and Screening which won the BMA Chairman's award in 2019. She is an author of over 500 original research papers. She has an international standing in Cancer Genetic Clinical Management and research, particularly management of individuals with mutations in the breast/ovarian/prostate cancer predisposition genes, BRCA1, BRCA2 and other genes and genetic predisposition to prostate cancer. She has been on several genetics advisory committees and edited the special edition of Familial Cancer: Cancer Genetics: New Ways of Working which reported on models of delivery of cancer genetics services.
She is a member of the learned societies: ESTRO, ESMO, ASHG, AACR, BAUS, ESHG, ASCO, BSGM and CGG UK
Her outside interests are Opera and Art.
Diseases, Medical Tests and TreatmentsClinical Genetics wrt cancer in adults
Cancer genetics
Prostate Genetics
Clinical genetics wrt cancer genetics in adults
Cancer genetics
Medical genetics
Prostate Genetics
Professor Eeles' oncological practice is in radiotherapy and chemotherapy for Uro-Oncology. Her cancer genetics practice involves cancer risk assessment, screening advice and management of increased cancer risk in adults for any cancer site. She is also an expert in how the new cancer genetics impacts on treatment decisions. She has edited a specialist textbook on Cancer Prevention and Screening which won the BMA Chairman's award in 2019. She is an author of over 500 original research papers. She has an international standing in Cancer Genetic Clinical Management and research, particularly management of individuals with mutations in the breast/ovarian/prostate cancer predisposition genes, BRCA1, BRCA2 and other genes and genetic predisposition to prostate cancer. She has been on several genetics advisory committees and edited the special edition of Familial Cancer: Cancer Genetics: New Ways of Working which reported on models of delivery of cancer genetics services.
She is a member of the learned societies: ESTRO, ESMO, ASHG, AACR, BAUS, ESHG, ASCO, BSGM and CGG UK
Her outside interests are Opera and Art.
Diseases, Medical Tests and TreatmentsClinical Genetics wrt cancer in adults
Cancer genetics
Prostate Genetics
Clinical genetics wrt cancer genetics in adults
Cancer genetics
Medical genetics
Prostate Genetics
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Professor Rosalind Eeles
Eğitim ve öğretim
-
2011–2017 MD · Medicine and Surgery
-
2017–2021 Residency · Onkoloji
-
2021–2022 Fellowship · Subspecialty training
Kariyer ve atamalar
-
2021-09–2022-08 Junior consultant
Lisanslar ve sigorta
Tıbbi lisanslar
GB — Organización Médica Colegial de España (OMC)
Kurul sertifikaları
European Board of Onkoloji
Mesleki sorumluluk sigortası:
Allianz Professional · 3,000,000 EUR kapsam · No claims on file
Gerçekleştirilen prosedürler
| Prosedür | Kod | Toplam sayı |
|---|---|---|
| GP consultation | 99213 | 2,293 |
| Annual physical exam | 99395 | 91 |
| Vaccination administration | 90471 | 1,155 |
| Minor procedure (skin) | 17110 | 740 |
Hizmetler ve fiyatlandırma
| Hizmet | Süre | Yöntem | Fiyat |
|---|---|---|---|
| New patient consultation (60m) | 60 dk | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 dk | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 dk | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 90 dk | in_clinic | 720.00 EUR |
Ofis, ekip ve uygulamada
Videolar
Araştırma ve yayınlar
h-endeksi: 15 · i10: 5
-
Outcomes of Onkoloji in adults — a multi-centre cohort
DOI: 10.4089/euroclin.2025.0 · PMID: 39603241 · alıntılayan 125
-
European registry analysis of Onkoloji outcomes
DOI: 10.5218/euroclin.2024.1 · PMID: 35056828 · alıntılayan 159
Davetli konuşmalar
- Practical updates in Onkoloji European Annual Congress (Onkoloji) · Vienna · 2024 · invited
- Single-centre experience in Onkoloji National Society Meeting · London · 2023 · oral abstract
Ödüller ve üyelikler
Ödüller
- 🏆 Top-rated Onkoloji — London · EuroClinics Patient Choice · 2025 · regional
Topluluk üyelikleri
- WONCA Europe — Family Doctors — Member · 2022 yılından beri
- national college of family doctors — Member · 2022 yılından beri
- European Union of Medical Specialists (UEMS) — Member · 2022 yılından beri
Bu doktorun makaleleri
- Patient education Patient guide to Onkoloji
- Awareness When should you see a onkoloji?
Uluslararası hastalar için
- Koordinatör
- Patient liaison · professor.rosalind.eeles.2@euroclinics.example
Konum
1 etiketHasta yorumları
Deneyiminizi paylaşın — diğer hastaların doğru doktoru bulmasına yardımcı olun. Yorum yaz →
Son yorumlar
-
★★★★★ ✓ Doğrulanmış Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Doğrulanmış Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Doğrulanmış Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
